Btk inhibitor 2

CAT: 0013-GTR19156048-01Size: 200 mgDry Ice: NoHazardous: No

1 / 1

CAT#:0013-GTR19156048-01Size:200 mg

Selected

24/48H Stock Items & 2 to 6 Weeks non Stock Items.

Quick Request Actions

Description

Btk inhibitor 2 is a BTK inhibitor extracted from patent US 20170224688 A1 (BGB-3111 analog) .

CAS Number

1558036-85-3

Product Name Alternative

BGB-3111 analog

Field of Research

Pharmacology & Drug Discovery; Cell Biology

Purity

>98% (HPLC)

Solubility

DMSO:75 mg/mL (173.82 mM; Need ultrasonic and warming)

Smiles

C=CC (=O) N1CCC[C@H] (C1) N2C (=C (C (=N2) C3=CC=C (C=C3) OC4=CC=CC=C4) C (=O) N) N

Molecular Formula

C24H25N5O3

Molecular Weight

431.49

Storage Conditions

Storage temperature: -20°C. Stability: ≥ 2 years

Notes

For research use only.

Related Products

Catalog	Name
GTR19206370-01	BTK inhibitor 10
GTR19166821-01	BTK inhibitor 17
GTR19212626-01	BTK inhibitor 20
GTR19206369-01	BTK inhibitor 13
GTR19184562-01	BTK inhibitor 18
GTR19188621	BTK inhibitor 19
GTR19191524-01	Btk inhibitor 1 hydrochloride
GTR19192188-01	BTK inhibitor 1 (Compound 27)
GTR19184190-01	JAK3/BTK-IN-2
GTR19221582-01	PROTAC BTK Degrader-2

Catalog	Name
105-350	Ribunuclease Inhibitor / RNase Inhibitor
880001	Inhibitor A
TBI1188-25MG	Xanthohumol, VCP inhibitor / Autophagy inhibitor
TBI2547-10MG	FAK inhibitor 14, FAK inhibitor
TBI2616-5MG	Oridonin, HSP70 inhibitor; Inflammasome inhibitor
SF2784-10mM	AKT inhibitor VIII (Akt inhibitor)
TBI2877-200UG	Conglobatin, NFAT inhibitor; HSP90 inhibitor
TBI2567-1MG	Herbimycin A, HSP90 inhibitor; Src inhibitor
TBI2047-50MG	DRB, Transcription inhibitor; CK2 inhibitor
TBI4861-25MG	GSK872, Necroptosis inhibitor / RIP3 inhibitor